Judith Stangl‐Kremser

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Alexander B. Zaslavsky, Mackenzie Adams, Xuhong Cao et al. · Scientific Reports · 2020 · 69 citations · Full text

Life Sciences, Immunology, Oncology +17

Prostate-Specific Membrane Antigen–Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of ²²⁵Ac-J591

Scott T. Tagawa, Charlene Thomas, Oliver Sartor et al. · Journal of Clinical Oncology · 2023 · 67 citations · Full text

Medicine, Oncology, Pharmacology +17

Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia

Judith Stangl‐Kremser, Rodrigo Suarez‐Ibarrola, D. D Andrea et al. · Prostate Cancer and Prostatic Diseases · 2019 · 39 citations

Medicine, Oncology, Urology +17

Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder

Judith Stangl‐Kremser, David D’Andrea, Mihai Dorin Vartolomei et al. · Urologic Oncology Seminars and Original Investigations · 2018 · 35 citations

Medicine, Oncology, Radiation Oncology +17

Development of a prognostic model for survival time prediction in castration-resistant prostate cancer patients

Judith Stangl‐Kremser, Andrea Mari, Rodrigo Suarez-Ibarrola et al. · Urologic Oncology Seminars and Original Investigations · 2020 · 27 citations

Medicine, Oncology, Urology +16